The purpose of the proposed trial is to determine if there is a difference in EGFR phosphorylation in bladder epithelium (adjacent normal appearing) 24 hours post-study dose, between patients randomized to erlotinib weekly as compared to placebo.

Agency
National Institute of Health (NIH)
Type
Station Support Contracts (N03)
Project #
261201200033I-0-26100002-1
Application #
8762943
Study Section
Project Start
2013-09-20
Project End
2016-03-31
Budget Start
Budget End
Support Year
Fiscal Year
2013
Total Cost
$559,231
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715